CHERRY Aktie 112129002 / DE000A3CRRN9
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
|
12.08.2025 08:59:03
|
EQS-News: Cherry SE: CHERRY Digital Health Receives Provider Approval for TI Messenger
|
EQS-News: CHERRY SE
/ Key word(s): Regulatory Approval
Munich, 12 August 2025 – CHERRY Digital Health has reached another important milestone: The company has received official provider approval for the TI Messenger from gematik. This approval marks a decisive step in CHERRY’s efforts to offer innovative solutions for the digitalization of healthcare. The CHERRY TI Messenger enables secure, GDPR-compliant, and cross-sector communication in the healthcare sector. Medical professionals can now communicate in real time, exchange findings and ask questions about medications — all via a single, user-friendly platform that can be used on both computers and smartphones. This allows flexible, device-independent use, significantly simplifying communication in healthcare. Why is the TI Messenger needed? Currently, many healthcare providers still rely on fax, telephone, and analog communication channels. The TI Messenger offers a modern, digital alternative that meets the highest security standards and significantly increases communication efficiency. Unlike conventional messaging services like WhatsApp, the TI Messenger complies fully with GDPR requirements and is approved by gematik. This ensures the highest security standards for sensitive medical data and promotes collaboration across different healthcare sectors. Additionally, the TI Messenger is continuously being further developed. By the end of the third quarter, TI-M Pro will be available, enabling communication with patients and health insurance providers as well. Dr. Philip Groth, Managing Director of CHERRY Digital Health, comments: " The provider approval by gematik confirms the quality and security of our TI Messenger solution. We are now ready to enter the market together with our partners and make a significant contribution to the digitalization of healthcare. Our goal is to make communication in the healthcare sector more efficient, secure, and user-friendly." Key advantages of the CHERRY TI Messenger:
CHERRY TI Messenger is based on innovative technology from Awesome Technologies and was developed specifically for the needs of the German healthcare system. It complements the CHERRY Digital Health portfolio. With this provider approval, CHERRY Digital Health underlines its position as a leading provider of health technologies and a reliable partner for all stakeholders in healthcare. For more information about the CHERRY TI Messenger, please click here.
About CHERRY Digital Health CHERRY Digital Health is a leading provider of health technologies. With innovative products such as readers for health cards, hygiene keyboards and its own SaaS solution, the company sets new standards in the equipment of clinics, practices and pharmacies. Through close cooperation with hospitals, doctors' practices and medical professionals, CHERRY Digital Health ensures the highest standards and customer-oriented solutions. Certified quality and continuous development make CHERRY Digital Health a reliable partner for all players in the healthcare sector.
PRESS CONTACT Lauren Sawyer CHERRY Press Team
PRESSEKONTAKT Claire Dove CHERRY Presseteam cherry@piabo.net
12.08.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Cherry SE |
| Rosental 7, c/o Mindspace | |
| 80331 Munich | |
| Germany | |
| ISIN: | DE000A3CRRN9 |
| WKN: | A3CRRN |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2182490 |
| End of News | EQS News Service |
|
|
2182490 12.08.2025 CET/CEST
Nachrichten zu CHERRY
Erfolgsfaktoren hinter starker Performance – Karsten-Dirk Steffens zu Gast im BX Morningcall
Einmal pro Monat laden Investment-Stratege François Bloch und Börsen-Experte David Kunz spannende Persönlichkeiten aus der Finanzbranche zum Interview ein.
In einem exklusiven Gespräch gibt Karsten-Dirk Steffens, CEO Schweiz von Aberdeen Investments, Einblicke in seine persönliche Motivation, die Entwicklung des Unternehmens in der Schweiz sowie die wichtigsten Trends für institutionelle und private Anleger.
Themen des Interviews:
– 15 Jahre Aberdeen Investments in der Schweiz – Rückblick und Zukunft
– Unterschiede zwischen institutionellen Kunden und internationalen Investoren
– Aktuelle Schwerpunkte bei Pensionskassen und Versicherungen (u. a. Aktienallokation)
– Nachhaltigkeit & ESG – Renaissance für Privatanleger vs. klare Standards bei Pensionskassen
– Alternative Anlagen: Private Markets, Infrastruktur, Private Debt
– Demokratisierung von Private Markets
– Chancen durch Digitalisierung, Blockchain und Tokenisierung
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Aktien in diesem Artikel
| CHERRY | 0.61 | -7.25% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Zinspolitik im Fokus: SMI verabschiedet sich tiefer ins Wochenende -- DAX beendet Handel wenig bewegt -- US-Börsen schliessen uneinheitlich -- Asiens Börsen schliessen mehrheitlich in GrünAm heimischen Aktienmarkt ging es vor dem Wochenende nach unten. Anleger in Deutschland hielten sich bedeckt. Die US-Börsen bewegten sich vor dem Wochenende in unterschiedliche Richtungen. An den grössten Börsen in Asien ging es zum Wochenschluss überwiegend aufwärts.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |